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Abstract
Dendritic cells (DCs) are essential antigen-presenting cells for the induction of T cell immunity against HIV. On the other
hand, due to the susceptibility of DCs to HIV infection, virus replication is strongly enhanced in DC–T cell interaction via an
immunological synapse formed during the antigen presentation process. When HIV-1 is isolated from individuals newly
infected with the mixture of R5 and X4 variants, R5 is predominant, irrespective of the route of infection. Because the early
massive HIV-1 replication occurs in activated T cells and such T-cell activation is induced by antigen presentation, we
postulated that the selective expansion of R5 may largely occur at the level of DC–T cell interaction. Thus, the
immunological synapse serves as an infectious synapse through which the virus can be disseminated in vivo. We used
fluorescent recombinant X4 and R5 HIV-1 consisting of a common HIV-1 genome structure with distinct envelopes, which
allowed us to discriminate the HIV-1 transmitted from DCs infected with the two virus mixtures to antigen-specific CD4
+ T
cells by flow cytometry. We clearly show that the selective expansion of R5 over X4 HIV-1 did occur, which was determined
at an early entry step by the activation status of the CD4
+ T cells receiving virus from DCs, but not by virus entry efficiency or
productivity in DCs. Our results imply a promising strategy for the efficient control of HIV infection.
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Introduction
HIV-1 infects T cells and monocyte lineage cells, including
macrophages and dendritic cells (DCs), through CD4, the primary
receptor for entry. The cellular tropism of HIV-1, i.e., macro-
phage (M)-tropic or T-cell line (T)-tropic, is determined by
chemokine receptors. Depending on whether they mainly use the
CCR5 or CXCR4 entry coreceptors, primary isolates are defined
as R5 for M-tropic and X4 for T-tropic variants, respectively [1].
Despite the fact that the HIV-1 present in infected individuals
frequently comprises the mixture of R5 and X4, virus isolated
from individuals newly infected through sexual, parenteral, or
mother-to-child transmission is also predominantly R5 [2,3,4].
During the clinical course of disease progression, the phenotype of
the virus may evolve from R5 to X4 or to R5/X4-dual tropic
[5,6,7], and X4 virus has been shown to be associated with a
decline in CD4
+ T cell counts and the onset of clinical symptoms
of AIDS [8]. However, R5 and X4 viruses are equally cytopathic
[9], and R5 virus isolated from patients with late-stage disease are
similarly pathogenic to X4 in vitro [10]. These findings suggest that
an yet-unknown selective mechanism that favors R5 virus exists
during transmission and/or the early phases of infection in the
host (review in [11]).
DCs are important antigen-presenting cells that initiate an
immune response by activating naı ¨ve and memory CD4
+ T cells
[12]. Although it is known that DCs are susceptible to HIV-1
infection, virus productivity from DCs and R5/X4 preferences for
DCs vary (see review in [13]). This could be attributed in large
part to the heterogeneous nature of DC sources, maturation levels,
proliferative capacities, methods for isolation, and culture
conditions. Importantly, all DC subsets express CD4 and varying
levels of CXCR4 and CCR5.
Because of the low frequency of DCs in vivo, blood monocytes
are often utilized as representative myeloid DCs for the study of
HIV-1 infection. We showed earlier that although monocyte-
derived DCs (MDDCs) generated in vitro are susceptible to X4 and
R5 HIV-1 infection, R5-infected DCs are poorly productive
compared with R5-infected macrophages of the same monocyte
origin [14]. Nevertheless, HIV-infected MDDCs efficiently
transmit virus to autologous CD4
+ T cells [15,16,17], by close
contact between MDDCs and CD4
+ T cells. Thus, when HIV-
infected DCs present antigens to CD4
+ T cells in lymphoid organs,
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program proceeds, which allows virus transmitted from DCs to
replicate in activated CD4
+ T cells. This interaction is called an
infectious synapse [18,19]. Thus, efficient HIV transmission from
DCs to CD4
+ T cells through infectious synapses may play a
central role not only for the massive expansion of HIV following
initial infection, but also for generating latent infection in HIV-
specific memory CD4
+ T cells [13].
The expression level of CXCR4 does not appear to be a crucial
factor of X4 replication, because most circulating hematopoietic
cells, including CD4
+ T cells and DCs [20], or submucosal
lymphocytes [21] express CXCR4 albeit at various levels. Although
the abundant CCR5 expression in activated/memory CD4
+ T cells
in submucosa may explain the preferential sexual transmission of
R5 HIV-1, there are many more CXCR4
+ CD4
+ T cells than there
are CCR5
+ CD4
+ T cells in the blood [11,22]. Furthermore,
MDDCs, and macrophages from the same individual express
similarly low levels of CCR5 [23] despite large differences in R5
virus productivity. Cavrois et al. recently analyzed thefusionactivity
of labeled virion with DC membranes and showed that the fusion
efficiency of R5 declined as DCs matured and CCR5 expression
decreased, and that X4 fusion efficiency did not change with
maturation [24]. On the other hand, Pion et al. showed that fusion
of X4 with immature DCs was markedly inefficient compared with
that of R5, and that this inefficiency was not complemented by
ectopic expression of CXCR4 [25]. They hypothesized that an as-
yet unknown env-specific block early in the virus infection cycle
occurs in DCs, which is not due solely to surface expression level of
chemokine receptors.
The state of T-cell activation determines the level of HIV-1
replication. HIV-1 replication in resting primary CD4
+ T cells is
inefficient at every level after entry: reverse transcription, nuclear
import, integration, and transcription [26,27]. Interestingly, a
significant replicative advantage of R5 over X4 HIV-1 in some
CD4
+ T cell clones is reported and X4-dependent restriction of
HIV replication is rescued by T cell receptor (TcR) stimulation
[28]. In TcR-stimulated CD4
+ T cells, R5, but not X4, HIV-1
efficiently replicates in the absence of MEK/ERK signaling,
whereas nuclear import of X4 HIV-1 is dependent on the MEK/
ERK pathway [29]. Recently, Cicala et al. showed that R5 ENV
up-regulates the expression of genes belonging to MAP kinase
pathways and genes regulating the cell cycle to a greater extent
than X4 ENV [30]. Stronger modulation of transcription by R5
than by X4 viruses in CD4
+ T cells was also reported [31]. These
results suggest that R5 HIV-1 has an advantage in establishing the
infection cycle in CD4
+ T cells. The question is how this
mechanism contributes to the selective expansion of R5 virus early
in HIV-1 infection.
To study the preference of R5 or X4 HIV-1 transmission during
DC-T cell interaction, we produced highly replication-competent,
fluorescent viruses of X4 and R5 type. We analyzed the HIV-1 life
cycle in MDDCs and CD4
+ T cells, before and after coculture, by
quantitative PCR (qPCR) and FACS. Although the infection
process progressed at an equal rate in MDDCs infected with either
R5 or X4 virus, R5 virus predominantly replicated in CD4
+ T
cells which are activated by antigen-presenting HIV-infected
MDDCs.
Results
HIV-1 expressing EGFP or DsRed is replication competent
in PHA-activated PBMCs
We generated fluorescent X4 (HIV-1NL-D) and R5 (HIV-1NLAD8-
D) viruses. The structure of these provirus clones and HIV-1NL-E
[32] was depicted in Fig. 1A. The co-receptor usage of these viruses
was determined by 1G5 or1G5/CCR5 cells, which contain a LTR-
driven luciferase gene [33]. As shown in Fig. 1B, both 1G5 and
1G5/CCR5 are infected with X4 type virus (HIV-1NL-E and HIV-
1NL-D),whereas 1G5/CCR5,butnot 1G5,isinfected with R5HIV-
1 (HIV-1NLAD8-D), indicating the expected coreceptor usage.
By combining X4 HIV-1NL-E and R5 HIV-1NLAD8-D, it became
easy to monitor their replication in individual cells using FACS.
These viruses were prepared by transfecting proviral DNA into
293T cells. We infected PBMCs stimulated with phytohemagglu-
tinin (PHA blasts) from two donors with the same p24 Gag
amount of the prototype virus HIV-1NL432 or with fluorescent
viruses HIV-1NL-E, HIV-1NL-D, or HIV-1NLAD8-D and then
monitored the kinetics of HIV-1 replication (Fig. 2A). Because
nef is not deleted in these constructs, the infectivity of the
fluorescent viruses is preserved and comparable to that of wild-
type virus. When cells were analyzed by FACS at 7 d post-
infection (dpi), we were able to clearly detect EGFP- or DsRed-
positive CD3
+ T cell populations (Fig. 2B). Therefore, these
fluorescent viruses are useful tools with which to identify HIV-
infected cell populations.
HIV-1 transmitted from infected MDDCs to CD4
+ T cells
during antigen presentation is predominantly the R5
variant
Next, we determined which HIV-1 variant preferentially
replicates in CD4
+ T cells that have been activated by interacting
with HIV-infected immature MDDCs. We mixed an equal
amount of p24-measured HIV-1NL-E and HIV-1NLAD8-D, and
infected MDDCs. We then cocultured the infected MDDCs with
allogeneic CD4
+ T cells. As shown in Fig. 3A, HIV-1 replication
was detectable at 7 dpi in the culture supernatant of the MDDC–
T cell coculture of DCs (DC-1 or DC-2) and CD4
+ T cells (allo T-
3 or allo T-4). As reported previously, MDDCs themselves
produce little if any virus during cultivation [14], and we were
unable to detect EGFP
+ or DsRed
+ MDDCs at 7 dpi (data not
shown). When day 3 PHA blasts were directly infected with the
virus mixture, cells infected with X4 viruses expressing EGFP
(HIV-1NL-E) predominated at 7 dpi (Fig. 3B). This may be due to
the reduced expression of CCR5 in day 3 PHA blasts [22]. In
contrast, in most of the combinations of MDDCs and allogeneic
Author Summary
The cellular tropism of HIV-1 is determined by the binding
of HIV-1 envelope to chemokine coreceptors, CCR5 or
CXCR4, in addition to a major entry receptor, CD4. The
mystery still now is that despite the mixed infection of
CCR5-utilizing (R5) and CXCR4-utilizing (X4) HIV-1 in many
AIDS patients, R5 is predominantly isolated from newly
infected individuals whatever the mode of infection.
Because the early massive HIV-1 replication occurs in
activated T cells and such T-cell activation is induced
initially by antigen-presenting DCs, we postulated that the
selective expansion of R5 may largely occur at the level of
antigen-dependent DC–T cell interaction, called immuno-
logical synapse. Thus, the immunological synapse serves as
an infectious synapse through which the virus can be
rapidly disseminated in vivo. In this study, we prepared X4
and R5 HIV-1 expressing red or green fluorescence and
showed that the selective expansion of R5 over X4 did
occur, depending on the activation status of CD4
+ T cells
receiving virus from DCs, but not by virus entry efficiency
or productivity in DCs.
Predominant DC–T Cell Transmission of R5 HIV-1
PLoS Pathogens | www.plospathogens.org 2 January 2009 | Volume 5 | Issue 1 | e1000279CD4
+ T cells (more than 10), cells infected with R5 virus
expressing DsRed (HIV-1NLAD8-D) were the predominant popu-
lation, producing virus at 10 dpi (Fig. 3C). The representative
results of two MDDC donors (DC-1 and DC-2) cocultured with
allogeneic T cells from two donors (T-3 and T-4) were shown here.
Of note, a substantial replication of X4 virus was detected only in
DC-1/allo T-3 combination, indicating that the activation of this
donor’s CD4
+ T cells (T-3) by allogeneic DC (donor-1) is
exceptionally powerful.
We also examined the replicability of R5 and X4 virus under
physiological conditions in which DC–T cell interactions occur
during antigen-specific immune responses. As shown in Fig. 3D,
R5 virus replicated predominantly in PPD- and CMV-reactive
CD4
+ T cells at 9 dpi (middle and right). In PHA- stimulated T
cells, however, both R5 and X4 virus were able to replicate at
7 dpi (left), which is quite similar situation to DC-1/allo T-3
combination (Fig. 3C). We obtained consistent results with cells
from several donors during both allogeneic and antigen-specific
interactions between MDDCs and CD4
+ T cells. Our results
suggest that R5 virus has an advantage over X4 virus during
transmission from MDDCs to CD4
+ T cells.
Similar Infectivity of X4 and R5 HIV-1 in MDDCs
There is some controversy regarding the difference between X4
and R5 virus susceptibility among DC subsets. Some reports
indicate that immature MDDCs are more susceptible to R5 virus
than to X4 [16,34,35], which may partly explain predominant R5
transmission. Therefore, we felt that it was necessary to determine
the efficiency of infection of X4 and R5 in MDDCs. First, we
checked the level of coreceptor expression in immature MDDCs.
The representative results of several individuals are shown in
Fig. 4A. The lower expression level of CCR5 compared with
CXCR4 (Fig. 3A) in immature MDDCs is quite consistent with
the pattern reported by Cavrois et al. [24], who utilized exactly the
same protocol for MDDC preparation.
To analyze early steps after HIV-1 entry, we infected MDDCs
with the same p24-measured amount of either HIV-1NL-E or HIV-
1NLAD8-D and prepared cell lysates at 8 h post-infection (hpi). We
measured the amount of distinct forms of proviral DNA (R-U5 and
U5-gag) by qPCR as previously described [36]. The amount of
these DNA forms was normalized to that of b-globin. Unfortu-
nately, the copy number of R-U5, the earliest reverse transcription
product in MDDCs, was too low and varied too much among
Figure 1. Genomic structure and co-receptor usage of recombinant HIV-1 encoding EGFP or DsRed. (A) The structure of provirus DNA
encoding EGFP or DsRed designated as pNL-E and pNL-D for X4 HIV-1 and pNLAD8-D for R5 HIV-1. EGFP or DsRed is not expressed as a fusion protein
of Env because of one base insertion after the Env stop codon. Nef is also independently expressed under the control of IRES. To confirm the
coreceptor usage of these fluorescent HIV-1, 1G5 (B) cells, 1G5/CCR5 (C) cells were infected with HIV-1NL432 (parent strain), HIV-1NL-E, HIV-1NL-D, or HIV-
1NLAD8-D. After 48 h post-infection, cell lysates were prepared and the Luc assay was performed. The data represents the averages 6SD of three
independent experiments.
doi:10.1371/journal.ppat.1000279.g001
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X4 and R5. However, similar amounts of the late reverse
transcription product U5-gag were consistently detected in X4-
or R5-infected MDDCs. A representative result is shown in
Fig. 4B. We also tested the infectivity of these viruses in MDDCs
by utilizing HIV-1 in which the gene encoding Renilla luciferase
Figure 3. Transmission of HIV-1 from infected MDDCs to CD4
+ T cells. (A) Virus production as measured by in-house p24 antigen ELISA in
CD4
+ T cells cocultured with MDDCs infected with the same amount of HIVNL-E and HIVNLAD8-D Culture supernatants were harvested every 3–4 d. (B)
FACS analysis of PHA blast T cells which were directly infected with the mixture of R5 and X4 HIV-1 at 7 dpi. (C) allogeneic CD4
+ T cells cocultured
with HIV-infected MDDCs at 10 dpi. Live (PI
2) and CD3
+ T cells were gated. (D) FACS analysis of autologous CD4
+ T cells cocultured with infected
MDDCs in the presence of PHA (left), PPD antigen (middle) or CMV-infected cell lysate (right). Live (PI
2) and CD3
+ T cells were gated.
doi:10.1371/journal.ppat.1000279.g003
Figure 2. Replication of recombinant HIV-1 encoding EGFP or DsRed. (A) Concentration of X4 HIV-1 (HIVNL-432), X4 HIV-1 expressing EGFP
(HIVNL-E), X4 HIV-1 expressing DsRed (HIVNL-D), or R5HIV-1 expressing DsRed (HIVNLAD8-D) in PHA-stimulated PBMCs of two donors. Virus production
was monitored by in-house p24 antigen ELISA. (B) FACS analysis of HIV-1-infected T cells expressing EGFP or DsRed at 7 dpi.
doi:10.1371/journal.ppat.1000279.g002
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hRluc activities of R5 and X4 viruses did not differ in infected
MDDCs at 3 dpi (data not shown). Thus, our results suggest that
selective transmission of R5 over X4 HIV-1 from DCs to T cells is
not due to differences in early entry, reverse transcription,
integration, or transcription in MDDCs.
Selective transmission of R5 over X4 HIV-1 through an
infectious synapse depends on the T cell activation state
Suppose R5 and X4 viruses infect MDDCs and are transmitted
to CD4
+ T cells with similar efficiency, it could be that selective
replication of R5 virus in DC–T cell coculture depends on the
state of T cell activation. To determine whether this is so, we
controlled the activation state of CD4
+ T cells by varying TcR-
stimulation conditions, and then we analyzed the infectivity of
HIV-1NL-E and HIV-1NLAD8-D in these cells (Fig. 5A). Prior to
infection with HIV-1, autologous CD4
+ T cells were (1)
unstimulated, (2) stimulated with 5 mg/ml anti-CD3 and 10 mg/
ml anti-CD28 for 24 h (strong activation), (3) stimulated with the
same concentrations of anti-CD3 and anti-CD28 for 2 h (medium
activation), or (4) stimulated with 10-fold lower concentrations of
anti-CD3 and anti-CD28 for 2 h (weak activation). These CD4
+ T
cells were infected with the virus mixture and analyzed at 5 dpi.
Figure 4. Infectivity of HIV-1 in MDDCs. (A) Surface expression of CCR5 and CXCR4 in MDDCs. MDDCs were stained with anti-CCR5 (left) and
anti-CXCR4 mAb (right), or with isotype control mAbs (dotted line). The reproducible representative of the FACS profiles of several individuals is
depicted. (B) Quantitative PCR analysis of R5 (HIVNLAD8-D) and X4 (HIVNL-E) HIV-1-infected MDDCs. Data represent the average 6SD of three
independent experiments.
doi:10.1371/journal.ppat.1000279.g004
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+ T cells. (A) FACS analysis of primary CD4
+ T cells (1) unstimulated, (2)
stimulated with 5 mg/ml anti-CD3 and 10 mg/ml anti-CD28 for 24 h (strong activation), (3) stimulated with the same concentrations of anti-CD3 and
anti-CD28 for 2 h (medium activation), or (4) stimulated with 10-fold lower concentrations of anti-CD3 and anti-CD28 for 2 h (weak activation). Cells
were then infected with equal amounts of X4 and R5 HIV-1 and analyzed at 5 dpi. (B) Quantitative PCR analysis of CD4
+T cells separately infected with
either R5 or X4 HIV-1. R-U5 and U5-Gag was analyzed by qPCR in two donors. The amount of HIV-1–specific DNA per cell was normalized to b-globin
gene expression. The data represents the average 6SD of three independent experiments. **, P,0.005; ***, P,0.0005.
doi:10.1371/journal.ppat.1000279.g005
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two of the six donors. Notably, in the weakly activated CD4
+ T
cells, only R5 HIV-1 replicated (Fig. 5A-4), whereas both X4 and
R5 virus replicated in different cells following medium activation
(Fig. 5A-3), and cells that were doubly infected with both X4 and
R5 were detected after strong activation condition (Fig. 5A-2).
Using the same weak and medium activation conditions, we
quantified the early R-U5 and U5-gag forms of HIV-1 reverse
transcription products in CD4
+ T cells in these donors at 8 hpi.
The amount of R-U5 and U5-gag DNA did not differ significantly
between X4 HIV-1- and R5 HIV-1-infected CD4
+ T cells
following medium activation (Fig. 5B, left, blank and filled
column, respectively). Surprisingly, however, after weak activation,
the amount of proviral DNA was dramatically higher in the R5
HIV-1-infected cells compared with those cells infected with X4
(Fig. 5B, right) (**P,0.005 and ***P,0.0005, in Donor 1 and 2,
respectively). These results suggest that the activation state of
CD4
+ T cells is a key factor in determining selective R5 HIV
transmission and virus expansion during DC–T cell interactions.
As shown in Fig. 3, R5 was the HIV-1 variant predominantly
transmitted during antigen-specific DC and CD4
+ T cell
interaction. To determine whether or not the activation state of
CD4
+ T cells stimulated by antigen-presenting MDDCs is relevant
to that of CD4
+ T cells weakly TcR stimulated with anti-CD3 and
anti-CD28, we first analyzed the expression levels of CCR5 and
CXCR4 on CD4
+ T cells activated by anti-CD3 and anti-CD28
or MDDCs (Fig. 6). Primary resting CD4
+ T cells were cocultured
with allogeneic MDDCs (allo) for either 2 or 24 h. Alternatively,
primary resting CD4
+ T cells were either unstimulated, strong or
weak TcR stimulated for 2 h. We did not observe a substantial
difference with respect to the surface expression of HIV entry
coreceptors 2 h stimulation following any of the conditions. The
FACS profile of unstimulated and strongly TcR-stimulated CD4
+
T cells is depicted in Fig. 6A. Although these cells were also
analyzed for surface activation markers (CD69, CD25, and HLA-
DR), no difference was observed. We, therefore, compared the
mRNA expression levels of IFN-c and IL-2, two representative
markers of early TcR activation, in these cells by quantitative
reverse transcription-PCR (qRT-PCR). The results in cells from
two donors are shown in Fig. 6B. The expression level of IFN-c in
allo (oblique lined column) and weak (grey column) stimulation
was similar at 2 h and it increased more than 10-fold in strong
(black column) stimulation. After 24 h of weak stimulation, IFN-c
increased to a level equivalent to that seen after 2 h strong
stimulation (data not shown), but IFN-c expression in allo-
stimulated CD4
+ T cells did not reach the maximum level even
after 24 h. In both donors, IL-2 mRNA expression was detectable
only after strong stimulation for 24 h (data not shown). Thus, both
X4 and R5 HIV-1 replicate well in strongly activated CD4
+ T
cells, but R5 virus is the variant capable of replicating in CD4
+ T
cells during DC-mediated antigen-specific activation, which may
be more closely mimic in vivo situation.
Discussion
Why HIV-1 isolated from individuals newly infected with both
R5 and X4 variants should be predominantly R5, irrespective of
the route of infection, is a longstanding discussion [11]. Because
DCs are one of the initial targets for HIV-1 infection and a source
of virus dissemination, their role in AIDS pathogenesis has also
been the recent topic of much discussion [13,19,37]. HIV-infected
DCs, albeit at low productivity, may form infectious synapses with
CD4
+ T cells during antigen-specific immune response in draining
lymph nodes, and efficient HIV-1 transmission and expansion may
occur in this microenvironment. The question that we sought to
address was whether the predominance of R5 HIV-1 over X4 was
determined at the level of DCs or CD4
+ T cells and by what
mechanism. By analyzing R5 selection during antigen-dependent
MDDC–CD4
+ T cell HIV-1 transmission, we showed that
MDDCs were infected with R5 and X4 HIV-1 and produced
low but similar levels of proviral DNAs. We also found that while
HIV-1 transmission from MDDCs to CD4
+ T cells was
predominantly R5, transmission from MDDCs to preactivated
CD4
+ T cells in vitro was slightly more X4 predominant. Although
the possibility that this R5 dominancy is ascribed to a unique
property of HIV-1ADA envelope is not formally excluded, we
showed here that the selective expansion of R5 over X4 in vivo may
be determined by the activation status of CD4
+ T cells, but not by
the efficiency of virus entry or productivity in MDDCs. The
CCR5 and CXCR4 expression levels appear to contribute little to
the predominance of R5 HIV-1 transmission from MDDCs to
CD4
+ T cells.
DCs are thought to be involved in the sexual transmission of HIV-
1 [37]. Rescigno et al. showed that murine submucosal DCs extend
their dendrites to the intestinal luminal surface [38], indicating that it
may be possible for HIV to directly come into contact with and infect
DCs, although how susceptible human submucosal DCs are to X4
and R5 HIV-1 infection is not known. Supporting an alternative
infection hypothesis, Bomsel showed that HIV-1 entered through the
epithelial barrier and was transmitted to submucosal DCs and CD4
+
T cells by transcytosis [39]. Interestingly, Meng et al. reported that
human mucosal epithelial cells express CCR5, but not CXCR4. By
infecting these cells with equal amounts of R5 and X4 virus, only R5
HIV-1 variant was transmitted, which was determined based on the
sequence of the gp120 env V3 region [40]. In contrast, Bobardt et al.
recently demonstrated that genital epithelia expresses low levels of
CCR5 and CXCR4 and that only limited amounts of HIV-1 were
transcytosed, without no preference for R5 or X4 [41]. In a monkey
model of intravaginal simian immunodeficiency virus (SIV) infection,
the infected cells appeared to be DCs in the lamina propria or
intraepithelium [42,43]. However, because of the low productivity
HIV-1 in DCs, it will be quite difficult to clarify the role of
submucosal DCs during early HIV-1 infection in humans. What is
most important, however, is not the level of HIV-1 productivity in
infected submucosal DCs, but the migratory nature of these DCs to
regional lymph nodes.
Resting primary CD4
+ T cells are refractory to viral replication;
the magnitude of viral replication in these cells is closely linked to
their activation state [44]. The R5 HIV-1 envelope protein is
known to deliver a signal that activates T cells to some extent [30],
which may assist R5 HIV-1 following cell entry to accomplish
reverse transcription, nuclear transport, and integration. The lack
of such a signal through CXCR4 may explain why X4 virus is
more strongly restricted than is R5 virus in primary CD4
+ T cells
[29]. In fact, we showed that weak activation conditions support
R5 HIV-1 replication, whereas stronger activation conditions
support replication of both viruses equally well (Fig. 4). When
MDDCs interacted with alloantigen- or nominal antigen-specific
CD4
+ T cells through an immunological synapse, T cells received
a signal from TcR first, followed by secondary signals from
costimulatory adhesion molecules, resulting in early cytokine
production. The intracellular environment of activated T cells
under these conditions may be akin to the weak activation of T
cells by TcR. The expression level of IFN-c 2 h after T cell
activation by alloantigen or by weak TcR stimulation was similarly
low compared to that by strong TcR stimulation (Fig. 6B). We
conclude from these results that the initial T-cell activation occurs
weakly during DC–CD4
+ T cell interactions, and that this low
Predominant DC–T Cell Transmission of R5 HIV-1
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viral life cycle. It is known that the retrovirus integration in a single
cell is somehow limited process [45]. The CD4
+ T cells may have
come into contact with R5 and X4 HIV-1 produced by DCs with
similar efficiency through the synapse, allowing the two variants to
enter simultaneously into cells. However, once R5 HIV-1 is
integrated in weakly activated CD4
+ T cells, a delayed progression
of X4 HIV-1 life cycle may be outcompeted by R5 HIV-1 even if
the CD4
+ T cells are later fully activated.
In summary, we visualized selective replication of the R5 HIV-1
variant following interactions between infected MDDCs and
CD4
+ T cells. We do not ascribe this to increased infectivity of R5
virus over X4 virus in MDDCs, but, rather, to the activation state
of CD4
+ T cells when they encounter a low level of these viruses at
the infectious synapse. It is during antigen-specific interactions
between DCs and CD4
+ T cells that HIV-1 transmission occurs
most efficiently in vivo, and it is during these interactions that R5
virus replicates preferentially over X4 virus.
Figure 6. Analysis of CD4
+ T cell activation. (A) Primary CD4
+ T cells were stimulated with anti-CD3 (5 mg/ml)+anti-CD28 (10 mg/ml) (black bold
line), anti-CD3 (0.5 mg/ml)+anti-CD28 (1 mg/ml) (black line), or cocultured with allogeneic CD4
+ T cells for 2 h (gray line). Isotype control mAbs were
used as a negative staining control (shaded peak). (B) One-step qRT-PCR analysis of IFN-c mRNA expression in primary CD4
+ T cells. Primary CD4
+ T
cells were cocultured with allogeneic CD4
+ T cells for 2 or 24 h and then stimulated with anti-CD3 (5 mg/ml)+anti-CD28 (10 mg/ml) (IL-2 strong), anti-
CD3 (0.5 mg/ml)+anti CD28 (1 mg/ml) (IL-2 weak), or no TCR stimulation (IL-2) for 2 h. Total RNA was extracted and analyzed by qRT-PCR. The data was
normalized to EF-1a and the relative amount of IFN-c is shown. The data represents the average 6SD of three independent experiments.
doi:10.1371/journal.ppat.1000279.g006
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Construction of plasmids
The plasmid pNL-E is a pNL432 (GenBank #M19921)-based
proviral clone expressing EGFP, as described previously [32]. To
create the pNL432-based proviral clone pNL-D, which expresses
DsRed, a fragment of the DsRed gene, along with the pNL432 env
region from the Hpa I digestion site to 39 end of the env, was
amplified by PCR, digested with Hpa I and Not I, and then ligated
into the corresponding site in pNL-E. The EGFP and DsRed
genes are located downstream of env, followed by an internal
ribosome entry site (IRES) and nef.
To generate R5 tropic HIV-1, we constructed a proviral clone
called pNLAD8-D by digesting pNL432-based pNLAD8 DNA
(env is originated from HIV-1ADA strain, kindly provided by
Michael W. Cho, Department of Medicine, Case Western Reserve
University School of Medicine, Cleveland, OH, USA, GenBank
#AF004394) with BamHI and EcoRI and replacing X4 env with
R5 env fragments.
Luc assay
1G5 or 1G5/CCR5 cells were infected with 50 ng of p24-
measured amounts of HIV-1NL432, HIV-1NL-E, HIV-1NL-D,o r
HIV-1NLAD8-D per 1610
5 cells for 2 h, washing three times, and
then culturied. After 48 h post-infection, cell lysates were prepared
and the Luc assay was performed according to the manufacturer’s
instructions (Promega).
Preparation of HIV-1 virus stocks
To prepare HIV-1 virus stocks, human embryonic kidney cell
line 293T cells were transfected with 20 mg of pNL432, pNL-E,
pNL-D or pNLAD8-D using the calcium phosphate precipitation
method and then incubation for 48 h. Culture supernatant was
treated with benzonase (1 U/ml) for 30 min at 37uC, cleared by
filtration, and then frozen at 280uC. The amount of virus in each
culture supernatant was measured by in-house HIV-1 Gag p24
ELISA [17].
Cell culture
The 293T cells were maintained in Dulbecco’s Modified Eagle
Medium (Invitrogen [GIBCO], Carlsbad, CA, USA), supplement-
ed with 10% heat-inactivated fetal bovine serum (FBS), penicillin
(100 mg/ml), and streptomycin (100 mg/ml). 1G5 (obtained from
AIDS Research and Reference Reagent Program, USA) and
1G5/CCR5 cells (CCR5 transfectants of 1G5 cells) were
maintained in RPMI-1640 medium supplemented with 10%
FBS, penicillin (100 mg/ml), streptomycin (100 mg/ml) (10% FBS-
RPMI) and puromycin (2 mg/ml). CEMx174 CCR5/LTR-EGFP
cells were maintained in RPMI-1640 medium supplemented with
10% FBS, penicillin (100 mg/ml), streptomycin (100 mg/ml) (10%
FBS-RPMI), puromycin (2 mg/ml), and blasticidin (5 mg/ml) [36].
MDDC and T cells were prepared as described previously [46].
Blood samples were collected from healthy donors after we
received written informed consent, and the collection was
approved by the institutional ethical committee. The PBMCs
were separated by a ficoll-hypaque density gradient (Lymphosepal:
IBL, Gunma, Japan), enriched for CD14
+ cells with magnetic anti-
CD14 beads and a magnetic cell sorter (MACS, Miltenyi Biotec,
Cologne, Germany), and cultured for 7 d in the presence of
10 ng/ml IL-4 and 10 ng/ml GM-CSF (both from PeproTech
London, United Kingdom). CD4+ T cells were negatively selected
by depletion using the EasySep human CD4
+ T cell enrichment
kit (StemCell Technologies, Vancouver, Canada). The purity of
CD4
+ T cells was .98%, as assessed by FACScalibur (BD
Biosciences, San Jose, CA, USA).
Kinetics of virus production in PHA blasts
PHA blasts were prepared by stimulating PBMCs with 5 mg/ml
PHA and, 3 d later, infecting them with 20 ng of p24-measured
amounts of HIV-1NL432, HIV-1NL-E, HIV-1NL-D, or HIV-1NLAD8-
D per 1610
6 cells for 2 h, washing them three times, and then
culturing them with 10% FBS-RPMI containing a recombinant
interleukin-2 (IL-2) 50 U/ml. Culture supernatants were harvested
at 3–4 d intervals and viral production was monitored by in-house
HIV-1 p24 Gag antigen ELISA.
For flow cytometric analysis of fluorescent proteins, HIV-1-
infected PHA blasts were stained with APC-labeled anti-CD3
mAb for 15 min on ice, washed once, and resuspended in staining
buffer (PBS, 2% FBS, and 0.05% sodium azide) containing 1 mg/
ml propidium iodide (PI). These cells were analyzed by
FACScalibur using the Cell Quest program. The FACS data
were reanalyzed using Flowjo software by gating live (PI-negative)
CD3
+ T cells (Tree Star, San Carlos, CA, USA).
Quantitative PCR and RT-PCR analysis
HIV-1NL-E- or HIVNLAD8-D-infected MDDCs or CD4
+ T cells
were collected and total DNA was prepared at 6 and 18 hpi. For
the detection and quantification of individual forms of HIV-1
DNA, oligonucleotide primers and probe sequences were
specifically designed for the TaqMan assay as described elsewhere
[36]. All probes (Biosearch Technologies, Novato, CA, USA) were
59 labeled with the fluorophore FAM as the reporter dye, and 39
labeled with Black Hole Quencher-1 (BHQ-1) as the quencher
dye. The amount of HIV-1–specific DNA per cell was normalized
to that of the b-globin gene.
For allogeneic stimulation, primary CD4
+ T cells (1610
6) were
cocultured with allogeneic MDDCs (1610
5) in 96-well round
bottom plates for 2 or 24 h. The cells were then washed with PBS,
and anti-CD11c mAb was added to half of the cells to deplete
MDDCs from the DC–T cell coculture. After incubating for
15 min on ice, the anti-CD11c-reacted cells were incubated with
Dynabead M450 goat anti-mouse IgG (Dynal Biotech, Lake
Success, NY, USA) for 30 min at 4uC, and then CD11c
+ MDDCs
were removed using a magnet stand. For TcR stimulation,
primary CD4
+ T cells were left unstimulated, weakly stimulated
with 0.5 mg/ml anti-CD3 and 1 mg/ml anti-CD28, or strongly
stimulated with 5 mg/ml anti-CD3 and 10 mg/ml anti-CD28 for
2 h. Total RNA was extracted from these CD4
+ T cells, and qRT-
PCR analysis was performed to measure the level of IFN-c mRNA
expression using the SuperScript III Platinum SYBR Green One-
Step Quantitative RT-PCR system (Invitrogen). The sequences of
the qRT-PCR primers were as follows: IFN-c forward, 59-
tcccatgggttgtgtgttta-39 and IFN-c reverse 59-aagcaccaggcatgaaatct-
39. The amount of IFN-c mRNA was normalized to elongation
factor 1 alpha (EF-1a) mRNA expression. The reaction was
performed using an Mx3000P (Stratagene, La Jolla, CA, USA).
HIV-1 infection of MDDCs and transmission to CD4
+ T
cells
MDDCs were left uninfected or were infected with 200 ng each
of HIV-1NL-E and HIV-1NLAD8-D per 1610
6 cells for 2 h, washed
three times, and then cultivated for 24 h in 24-well culture plates.
HIV-infected or mock-infected MDDCs were collected, washed
with PBS, treated with 0.025% trypsin for 5 min at 37uC, and
then washed twice with 10% FBS-RPMI. MDDCs (0.5610
5 per
well) were cocultured with autologous or allogeneic CD4
+ T cells
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6 per well) in 96-well round-bottom plates. In some cases,
purified protein derivatives of 25 mg/ml Mycobacterium tuberculosis
(PPD) or a 10% final volume of CMV antigen (CMVAD169-
infected MRC-5 lysate, kindly provided by N. Inoue, The first
department of Virology, National Institute of Infectious Diseases,
Tokyo, Japan ) were added to the culture. The CD4
+ T cells
stimulated with the weak or strong IL-2 protocol, described above,
were left uninfected or were infected with 200 ng each of HIV-
1NL-E and HIV-1NLAD8-D per 1610
6 cells for 2 h, extensively
washed, and cultivated in 48-well tissue culture plates (1610
6 per
well) in 10% FBS-RPMI containing IL-2. These culture
supernatants were harvested at 3–4 d intervals, and viral
production was monitored by p24 antigen ELISA.
For flow cytometric detection of R5 (DsRed
+) and/or X4
(EGFP
+) HIV-1-infected CD4
+ T cells, cells were stained with
APC-labeled anti-CD3 mAbs, and PI
2 CD3
+ cells were analyzed
by FACScalibur using the Cell Quest program and reanalyzed
using Flowjo software.
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